바이오의약품 시장 조사를 위한 동결건조 서비스 – 규모, 점유율, 개발 및 미래 범위 2031

  • Report Code : TIPRE00009286
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 156
Buy Now

[연구 보고서] 바이오의약품 시장의 동결건조 서비스 규모는 2022년 20억 5,141만 달러에서 2028년 35억 8,655만 달러로 성장할 것으로 예상됩니다. 2023년부터 2028년까지 연평균 성장률(CAGR)은 9.9%로 예상됩니다.

바이오의약품 시장 성장을 위한 동결건조 서비스는 동결건조 제품에 대한 수요 증가와 전 세계적으로 빠르게 성장하는 계약 제조 및 동결건조 서비스에 기인합니다. .

바이오의약품 시장을 위한 동결건조 서비스는 서비스 유형, 최종 사용자 및 지역을 기준으로 분류됩니다. 이 보고서는 바이오의약품을 위한 동결건조 서비스 시장 동향, 기술 발전, 시장 역학, 주요 시장 플레이어의 경쟁 환경 분석과 같은 매개변수를 강조하면서 시장에 대한 통찰력과 심층 분석을 제공합니다.   

바이오의약품 시장을 위한 동결건조 서비스 – 전략적 통찰력 

바이오의약품 시장을 위한 글로벌 동결건조 서비스 

바이오의약품 시장을 위한 동결건조 서비스 – 시장 통찰력      

계약 제조 및 동결건조 서비스의 급격한 증가로 생물의약품 시장 성장을 위한 동결건조 서비스 추진

생물의약품 시장은 전 세계적으로 계속 확장되고 있습니다. 제약 산업의 주요 성장 동력이 될 수 있습니다. 최근 더 많은 치료용 생물학적 제제가 승인됨에 따라 바이오의약품 비경구 제조가 확대되었습니다. 생명공학 회사는 충전 및 마무리 요구 사항을 충족하고 미생물 오염 위험을 줄이기 위해 CMO(계약 제조 조직)에 아웃소싱합니다. 바이오제약 회사는 필요에 따라 용량과 기능을 제공하기 위해 위탁 제조 조직(CMO)에 의존합니다. 어떤 경우에는 CMO가 회사 생산의 상당 부분을 제공합니다.

사내 동결건조 기능과 운영을 설정하려면 전문 장비와 전문 지식이 필요합니다. 시간이 많이 걸립니다. 그러나 아웃소싱은 비용이 저렴하고 제조 프로세스의 효율성을 높입니다. 또한 이를 통해 생명공학 기업은 리소스를 다른 영역으로 전환할 수 있습니다. 따라서 의약품 개발자와 바이오제약 회사는 전체 생산 및 수율 비용을 절감하기 위해 이러한 작업을 CMO에 아웃소싱합니다. 몇 년 전만 해도 CMO 산업은 생명공학 기업에 추가 제조 역량이나 특정 서비스를 제공하는 틈새 서비스 시장이었습니다. 이제 많은 생명공학 기업은 초기 단계의 의약품 개발부터 상업적 규모의 제조에 이르기까지 다양한 서비스를 아웃소싱합니다. 생명공학 산업이 대규모 생산에서 틈새 및 표적 치료(맞춤형 의료)로 전환함에 따라 유연한 운영 능력, 생산 규모 및 다중 제품 운영에 대한 요구가 높아지고 있습니다. 이러한 모든 요인으로 인해 CMO에 대한 성향이 커지고 있습니다. 동결건조 작업을 위한 전문 시설과 전용 라인을 제공하는 CMO 중 하나가 Jubilant HollisterStier Contract Manufacturing & 서비스. CMO는 상업용 멸균 주사제와 전체 동결건조 서비스 제품군을 통해 1단계의 멸균 충전/완제품을 제공합니다. 증가하는 서비스 수요에 부응하기 위해 Jubilant는 새로운 385평방피트 규모의 동결건조기를 설치할 예정입니다. 따라서 바이오의약품 CMO의 역량과 가용성이 향상되면서 바이오의약품 시장 성장을 위한 동결건조 서비스가 가속화되고 있습니다.

서비스 유형별 글로벌 바이오의약품 시장을 위한 동결건조 서비스 – 2022년 vs 2028

바이오의약품 시장을 위한 동결건조 서비스 – 서비스 유형 기반 통찰력

서비스 유형에 따라 바이오의약품 시장을 위한 글로벌 동결건조 서비스는 상업용 제조, 동결건조 사이클 개발, 임상 제조 및 동결건조 분석 서비스로 분류됩니다. 상업용 제조 부문은 2022년 가장 큰 시장 점유율을 차지했습니다. 동결건조 사이클 개발 부문은 예측 기간 동안 가장 높은 CAGR을 기록할 것으로 예상됩니다.

바이오의약품 시장을 위한 동결건조 서비스 – 최종 사용자 기반 통찰력

최종 사용자를 기반으로 바이오의약품 시장을 위한 글로벌 동결건조 서비스는 제약 및 생명공학 회사, 연구 기관 등으로 분류됩니다. 제약 및 생명공학 기업 부문은 2022년에 가장 큰 시장 점유율을 차지했습니다. 연구 기관 부문은 예측 기간 동안 가장 높은 CAGR을 기록할 것으로 예상됩니다. 

바이오의약품 시장을 위한 동결 건조 서비스 기업은 무기 및 인수합병 등 유기적 전략. 최근 몇 가지 주요 시장 발전 사항은 다음과 같습니다.

  • 2022년 11월 LTI는 결핵 백신 후보 ID93/GLA-SE에 대한 개발, 공정 엔지니어링 및 임상 재료 준비에 참여한다고 발표했습니다. . 결핵백신이 임상 2상 시험에 성공적으로 도달했습니다. 이 연구는 에멀젼 기반 보조제를 함유한 열안정성 하위 단위 백신 후보의 성공적인 동결건조에 대한 첫 번째 보고서를 나타냅니다.
  • 2022년 5월 Jubilant HollisterStier LLC는 육군 계약과 미화 1억 4,960만 달러 규모의 협력 계약을 체결했습니다. 미국 보건복지부 산하 BARDA(생의학 첨단 연구 개발 기관)를 대신하여 JPEOCBRND(화학, 생물학, 방사능 및 핵 방어를 위한 합동 프로그램 실행 사무국)와 협력하여 사령부.
  • 2021년 10월, PCI Pharma Services(PCI)는 베드포드에 본사를 둔 최고의 계약 개발 및 제조 조직(CDMO)인 New England, Inc.(LSNE)의 동결건조 서비스 를 인수하기로 최종 계약을 체결했다고 발표했습니다. , 뉴햄프셔, 글로벌 사모펀드 회사 Permira 출신. 이번 인수로 미국(위스콘신주 뉴햄프셔)과 유럽(스페인)에 5개의 FDA 승인 시설이 추가되었으며, 앞으로 몇 달 안에 6번째 시설의 승인이 예상됩니다. 또한, 3개의 추가 시설이 개발 중입니다. 이러한 시설은 글로벌 30개 사이트 네트워크를 강화할 것입니다.
  • 2021년 7월, Albany Molecular Research, Inc.(AMRI)는 2021년 7월 12일부터 이름을 Curia로 변경한다고 발표했습니다. 새 이름은 연구개발(R&D)부터 상업 제조에 이르기까지 과학적 전문성과 광범위한 역량을 적용해 제약 및 생명공학 고객이 개선된 중요한 신제품을 개발할 수 있도록 함으로써 엔드투엔드 글로벌 CDMO로서의 회사의 전략적 포지셔닝을 강화합니다. 살아있습니다.     

회사 프로필 - 바이오의약품 시장을 위한 동결건조 서비스

  • ATTWILL Medical Solutions
  • Axcellerate Pharma LLC
  • Labyrinth Biopharma LLC
  • Berkshire Sterile Manufacturing
  • PCI Pharma Services
  • Curia Global Inc
  • Emergent BioSolutions Inc
  • Jubilant HollisterStier LLC
  • Biofortuna
  • Lyophilization Technology Inc.
  • SYNERLAB GROUP
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Who are the key players in the lyophilization services for biopharmaceuticals market?

Companies operating in the market are ATTWILL Medical Solutions; Axcellerate Pharma LLC; Labyrinth Biopharma LLC; Berkshire Sterile Manufacturing; PCI Pharma Services; Curia Global Inc; Emergent BioSolutions Inc.; Jubilant HollisterStier LLC; Biofortuna; Lyophilization Technology Inc.; and SYNERLAB GROUP.

What is lyophilization?

Lyophilization is a process of isolating a solid substance from a solution. It is also known as freeze-drying is a process. The process is carried by freezing the solution and evaporating under vacuum. It helps in optimizing lyophilization cycle times and improves stability for critically complexes of injectable during the parenteral product development.

What is the regional market scenario of the lyophilization services for biopharmaceuticals market?

Global lyophilization services for biopharmaceuticals market is segmented by region into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America is likely to continue its dominance in the lyophilization services for biopharmaceuticals market during 2023–2028. The US holds the largest share of the market in North America and is expected to continue this trend during the forecast period.

What are the driving factors for the lyophilization services for biopharmaceuticals market across the globe?

The growth of market is likely to grow due to factors such as rising demand for lyophilized products and rapid growth in contract manufacturing and lyophilization services across the world are expected to boost the growth of the global lyophilization service for biopharmaceuticals market. However, the market is likely to get impacted by the demerits associated with lyophilization process during the forecast period.

Which segment led the lyophilization services for biopharmaceuticals market?

Based on service type, the global lyophilization services for biopharmaceuticals market is divided into commercial manufacturing, lyophilization cycle development, clinical manufacturing, and freeze-drying analytical services. The commercial manufacturing segment held the largest share of the market in 2022. The lyophilization cycle development segment is expected to grow at the highest CAGR during the forecast period.

Which end user segment held the largest revenue (US$ Mn) in the lyophilization services for biopharmaceuticals market?

Based on end user, the global lyophilization services for biopharmaceuticals market is divided into pharmaceutical and biotechnology companies, research institutes, and others. The pharmaceutical and biotechnology companies segment held the largest share of the market in 2022. The research institutes segment is expected to grow at the highest CAGR during the forecast period.

The List of Companies - Lyophilization Services for Biopharmaceuticals Market

  1. ATTWILL Medical Solutions
  2. Axcellerate Pharma LLC
  3. Labyrinth Biopharma LLC
  4. Berkshire Sterile Manufacturing
  5. PCI Pharma Services
  6. Curia Global Inc
  7. Emergent BioSolutions Inc
  8. Jubilant HollisterStier LLC
  9. Biofortuna 
  10. Lyophilization Technology Inc.
  11. SYNERLAB GROUP     

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports